Targeting Water in the Brain: Role of Aquaporin-4 in Ischemic Brain Edema

Curr Drug Targets. 2019;20(7):748-755. doi: 10.2174/1389450120666190214115309.

Abstract

Brain edema primarily occurs as a consequence of various cerebral injuries including ischemic stroke. Excessive accumulation of brain water content causes a gradual expansion of brain parenchyma, decreased blood flow and increased intracranial pressure and, ultimately, cerebral herniation and death. Current clinical treatment for ischemic edema is very limited, therefore, it is urgent to develop novel treatment strategies. Mounting evidence has demonstrated that AQP4, a water channel protein, is closely correlated with brain edema and could be an optimal therapeutic target for the reduction of ischemic brain edema. AQP4 is prevalently distributed in the central nervous system, and mainly regulates water flux in brain cells under normal and pathological conditions. This review focuses on the underlying mechanisms of AQP4 related to its dual role in edema formation and elimination.

Keywords: Aquaporin-4; brain edema; central nervous system; stroke; therapeutic target; water channel..

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aquaporin 4 / metabolism*
  • Brain Edema / drug therapy
  • Brain Edema / metabolism*
  • Central Nervous System / metabolism*
  • Gene Expression Regulation
  • Humans
  • Molecular Targeted Therapy
  • Water / metabolism

Substances

  • AQP4 protein, human
  • Aquaporin 4
  • Water